[1]余国清.舒芬太尼应用于静脉术后镇痛及临床麻醉的效果[J].医学信息,2020,33(02):149-150.[doi:10.3969/j.issn.1006-1959.2020.02.045]
 YU Guo-qing.Effect of Sufentanil on Intravenous Analgesia and Clinical Anesthesia[J].Medical Information,2020,33(02):149-150.[doi:10.3969/j.issn.1006-1959.2020.02.045]
点击复制

舒芬太尼应用于静脉术后镇痛及临床麻醉的效果()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年02期
页码:
149-150
栏目:
药物与临床
出版日期:
2020-01-15

文章信息/Info

Title:
Effect of Sufentanil on Intravenous Analgesia and Clinical Anesthesia
文章编号:
1006-1959(2020)02-0149-02
作者:
余国清
(金溪县人民医院麻醉科,江西 金溪 344800)
Author(s):
YU Guo-qing
(Department of Anesthesiology,Jinxi County People’s Hospital,Jinxi 344800,Jiangxi,China)
关键词:
舒芬太尼静脉镇痛麻醉
Keywords:
SufentanilIntravenousAnalgesiaAnesthesia
分类号:
R614.2
DOI:
10.3969/j.issn.1006-1959.2020.02.045
文献标志码:
A
摘要:
目的 观察舒芬太尼应用于静脉术后镇痛及临床麻醉的效果。方法 选择2017年5月~2019年5月在我院接受手术治疗的患者60例,采用随机数字表法分为对照组和观察组,各30例。对照组采用芬太尼进行麻醉,观察组采用舒芬太尼麻醉,比较两组临床麻醉效果、术后疼痛评分以及临床不良反应。结果 观察组麻醉起效时间(3.51±1.22)min、清醒时间(26.81±7.09)min、自主呼吸恢复时间(7.98±1.22)min均低于对照组(9.11±2.56)min、(50.12±1.07)min、(14.23±2.18)min,差异有统计学意义(P<0.05);观察组术后疼痛评分为(3.32±0.58)分,低于对照组的(5.82±11.12)分,差异有统计学意义(P<0.05);观察组临床不良反应发生率为3.33%,低于对照组的16.67%,差异有统计学意义(P<0.05)。结论 舒芬太尼用于静脉术后镇痛及临床麻醉效果良好,可缩短患者清醒时间,减轻术后疼痛及不良反应发生率,促进患者术后恢复。
Abstract:
Objective To observe the effect of sufentanil applied in intravenous analgesia and clinical anesthesia. Methods A total of 60 patients who underwent surgical treatment in our hospital from May 2017 to May 2019 were selected and randomly divided into a control group and an observation group, with 30 cases in each group. The control group was anesthetized with fentanyl, and the observation group was anesthetized with sufentanil. The clinical anesthesia effects, postoperative pain scores, and clinical adverse reactions were compared between the two groups.Results The anesthesia onset time (3.51±1.22) min, awake time (26.81 ± 7.09) min, and spontaneous breathing recovery time (7.98±1.22) min in the observation group were all lower than those in the control group (9.11±2.56) min and (50.12±1.07) min (14.23±2.18) min, the difference was statistically significant (P<0.05); the postoperative pain score of the observation group was(3.32±0.58) points, which was lower than the control group’s(5.82±11.12) points,the difference was statistically significant (P<0.05); the incidence of clinical adverse reactions in the observation group was 3.33%, which was lower than 16.67% in the control group,the difference was statistically significant(P<0.05).Conclusion Sufentanil has a good effect on intravenous analgesia and clinical anesthesia. It can shorten the patient’s awakening time, reduce the incidence of postoperative pain and adverse reactions, and help promote postoperative recovery.

参考文献/References:

[1]沈隽,李东来.地佐辛联合舒芬太尼用于术后自控静脉镇痛的临床效果分析[J].中华临床医师杂志(电子版),2016,10(11):207-208. [2]程珺,王宇飞,李雄刚,等.舒芬太尼联合昂丹司琼静脉术后镇痛应用妇科手术的临床观察[J].现代生物医学进展,2015,15(22):4320-4322. [3]文竹,郑佳利.舒芬太尼和右美托咪啶应用于临床麻醉及术后镇痛的效果观察[J].医学综述,2014,2(21):3986-3987. [4]李秀杰.瑞芬太尼与舒芬太尼全身麻醉后对患者苏醒质量的影响观察[J].中国继续医学教育,2016,8(11):71-72. [5]孙祖波.舒芬太尼运用于静脉术后镇痛及临床麻醉的效果分析[J].中西医结合心血管病电子杂志,2016,4(23):192-193.

相似文献/References:

[1]侯 江.舒芬太尼联合右美托咪定用于临床麻醉的效果观察[J].医学信息,2018,31(03):144.[doi:10.3969/j.issn.1006-1959.2018.03.051]
 HOU Jiang.Clinical Observation on the Effect of Sufendate Combined with Dexlansoprazole in Clinical Anesthesia[J].Medical Information,2018,31(02):144.[doi:10.3969/j.issn.1006-1959.2018.03.051]
[2]龚立云.舒芬太尼经鼻给药与静脉给药在纤维结肠镜检查中疗效对比[J].医学信息,2018,31(06):135.[doi:10.3969/j.issn.1006-1959.2018.06.046]
 GONG Li-yun.Comparison of Efficacy of Sufentanil between Nasal and Intravenous Administration in Fibrocolonoscopy[J].Medical Information,2018,31(02):135.[doi:10.3969/j.issn.1006-1959.2018.06.046]
[3]赵 立,梁永新.瑞芬太尼联合丙泊酚应用于食道异物取出术的麻醉效果分析[J].医学信息,2018,31(11):93.[doi:10.3969/j.issn.1006-1959.2018.11.028]
 ZHAO Li,LIANG Yong-xin.Analysis of Anesthetic Effect of Remifentanil Combined with Propofol for Removal of Esophageal Foreign Body[J].Medical Information,2018,31(02):93.[doi:10.3969/j.issn.1006-1959.2018.11.028]
[4]张 燕,王永娟.舒芬太尼复合地佐辛用于痔上黏膜环切术后自控镇痛的剂量分析[J].医学信息,2019,32(04):140.[doi:10.3969/j.issn.1006-1959.2019.04.045]
 ZHANG Yan,WANG Yong-juan.Dose Analysis of Sufentanil Combined with Dizocine for Self-controlled Analgesia after Supraorbital Mucosal Circumcision[J].Medical Information,2019,32(02):140.[doi:10.3969/j.issn.1006-1959.2019.04.045]
[5]刘丹丹,王 彬,于雪晶.不同采血方法在血常规检验中的应用价值研究[J].医学信息,2019,32(07):172.[doi:10.3969/j.issn.1006-1959.2019.07.055]
 LIU Dan-dan,WANG Bin,YU Xue-jing.Study on the Application Value of Different Blood Collection Methods in Blood Routine Examination[J].Medical Information,2019,32(02):172.[doi:10.3969/j.issn.1006-1959.2019.07.055]
[6]王建华.舒芬太尼和地佐辛预防瑞芬太尼麻醉后疼痛过敏的效果比较[J].医学信息,2019,32(24):151.[doi:10.3969/j.issn.1006-1959.2019.24.054]
 WANG Jian-hua.Comparison of Sufentanil and Dezocine in Preventing Pain Allergy after Remifentanil Anesthesia[J].Medical Information,2019,32(02):151.[doi:10.3969/j.issn.1006-1959.2019.24.054]
[7]顾福莉,徐涑珅,石昌国.静脉用药不合理使用情况及原因分析[J].医学信息,2020,33(02):153.[doi:10.3969/j.issn.1006-1959.2020.02.047]
 GU Fu-li,XUSu-shen,SHI Chang-guo.Analysis of the Unreasonable Use of Intravenous Medication and Its Causes[J].Medical Information,2020,33(02):153.[doi:10.3969/j.issn.1006-1959.2020.02.047]
[8]齐佩君.小剂量舒芬太尼在剖宫产术麻醉中预防寒战和牵拉痛的临床效果观察[J].医学信息,2018,31(19):139.[doi:10.3969/j.issn.1006-1959.2018.19.042]
 QI Pei-jun.Clinical Observation of Low-dose Sufentanil in Preventing Chills and Pulling Pain in Cesarean Section Anesthesia[J].Medical Information,2018,31(02):139.[doi:10.3969/j.issn.1006-1959.2018.19.042]
[9]杜化娟.右美托咪定滴鼻和静脉给药对小儿腺样体切除术的镇静效果比较[J].医学信息,2020,33(04):115.[doi:10.3969/j.issn.1006-1959.2020.04.035]
 DU Hua-juan.Comparison of Sedative Effect of Dexmedetomidine Nasal and Intravenous Administration on Adenoidectomy in Children[J].Medical Information,2020,33(02):115.[doi:10.3969/j.issn.1006-1959.2020.04.035]
[10]刘丽丽.右美托咪定联合舒芬太尼对体外循环心脏瓣膜置换术患者围术期器官保护及术后认知功能的影响[J].医学信息,2022,35(17):95.[doi:10.3969/j.issn.1006-1959.2022.17.025]
 LIU Li-li.Effects of Dexmedetomidine Combined with Sufentanil on Perioperative Organ Protection and Postoperative Cognitive Function in Patients Undergoing Cardiopulmonary Bypass Cardiac Valve Replacement[J].Medical Information,2022,35(02):95.[doi:10.3969/j.issn.1006-1959.2022.17.025]

更新日期/Last Update: 2020-01-15